Praxis Precision Medicines (PRAX) Misses Q1 EPS by 284c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($2.84). Revenue for the quarter came in at $430 thousand.

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Shotspotter (SSTI) Misses Q2 EPS by 19c; Offers Guidance
• HeartFlow, Inc. (HTFL) Tops Q2 EPS by 12c
• Digimarc Corporation (DMRC) Tops Q2 EPS by 25c, Beats on Revenue